NewsRoom Articles - Page 88 of 606

TuesdayNov 28, 2023 4:20 pm

420 with CNW — UMass Study Concludes High Schoolers’ Likelihood to Use Cannabis Isn’t Heightened by Legalization

A new study has found that high schoolers are not as likely to use cannabis following the drug’s legalization. This finding weakens prior claims that youth who know or think that their friends, siblings or parents use cannabis may have a heightened risk for marijuana use and additional intervention and prevention strategies need to be implemented to reduce said risk. The study, which was carried out by researchers at the University of Massachusetts Amherst, included associate professor Jennifer Whitehill of health policy and management and Public Health and Health Sciences doctoral candidate, Faith English. Whitehill’s focus, as the study’s senior…

TuesdayNov 28, 2023 4:20 am

420 with CNW — Rescheduling Cannabis Could Lead to Broader Acceptance by the Mainstream Medical Industry

Moving cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA) could have significant implications for medical cannabis recommendations by doctors and potential insurance coverage for marijuana treatments. Currently, doctors refrain from prescribing state-regulated medical cannabis due to the risk of losing their licenses given that it lacks approval from the U.S. Food and Drug Administration (FDA). Even if the Drug Enforcement Administration (DEA) reschedules cannabis, the prohibition on doctors prescribing state-regulated medical marijuana (MMJ) products would persist. Nevertheless, doctors could continue to recommend non-FDA-approved cannabis products to individuals seeking MMJ cards, allowing them to register as…

MondayNov 27, 2023 4:20 pm

420 with CNW — Regulators in New York Reach Settlement Regarding Marijuana Business Licensing

Cannabis regulators in the state of New York have reached a settlement with veterans who had filed a suit over the licensing process in the state. The settlement’s completion will allow an injunction that was effected from August to be lifted. The temporary injunction, which was enacted by the state’s Supreme Court, has prevented hundreds of holders of conditional adult-use retail dispensary licenses from launching their businesses. Regulators in the state launched the recreational retail-dispensary program to afford those who were disproportionately affected by the drug war before marijuana became legal an opportunity to enter the legal marijuana industry. The…

MondayNov 27, 2023 9:00 am

Software Effective Solutions Corp. (SFWJ) Is ‘One to Watch’

MedCana announced in May 2023 full-scale production of non-THC cannabis for export to Europe The company earlier in 2023 commenced construction of crop production infrastructure at sites in Central and South America MedCana has engaged in talks with the government of Argentina about starting production in that country The company in 2023 acquired the assets of Tokan Corp., including an ERP software platform for the cannabis industry Software Effective Solutions (d/b/a MedCana) (OTC: SFWJ) is a global infrastructure and holding company in the cannabis industry. MedCana currently has five companies focused on pharmaceutical cannabis production, as well a software company…

MondayNov 27, 2023 4:20 am

420 with CNW — NORML Deputy Director Calls Out Republican Politicians for Trying to Subvert Voters’ Wishes on Marijuana

Paul Armentano, who works as deputy director at NORML, a nonprofit aimed at advocating for the reform of marijuana laws, recently penned a post for The Hill in which he expressed concerns about a growing trend in which GOP lawmakers in different states have actively taken steps to subvert the wishes of voters with regard to marijuana legalization. Recently, Ohioans made a decisive choice in favor of Issue 2 — a citizen-driven ballot initiative marking a significant step toward legalizing the cultivation, possession and sale of recreational cannabis. The vote was in line with a broader national trend where, across…

WednesdayNov 22, 2023 4:20 pm

420 with CNW — Study Suggests Cannabis Enables Users Quit Prescription Sleep Medications

A recent study into the sleep habits of marijuana users facing sleep difficulties shows that a majority of participants prefer cannabis over other sleep aids, citing improved outcomes the following morning and fewer side effects. The consumption of CBD, THC and myrcene-infused joints or vaping products emerged as particularly popular choices among participants. Contrasted with conventional sleep aids or abstaining from them altogether, respondents conveyed a heightened sense of refreshment, focus and improved functionality in the mornings after using cannabis. This was coupled with a decrease in nausea and headaches. However, users did acknowledge some adverse effects, such as waking…

WednesdayNov 22, 2023 4:20 am

420 with CNW — Gallup Poll Finds Most Americans Disenchanted with Federal Drug Policy

A new survey has found that more than 50% of Americans believe the country has lost ground in the war on drugs. The poll, conducted by Gallup, also showed that 24% of respondents believed America had made progress. This is quite a difference from responses given on the same query in a 2019 survey, which stood at 30% for losing ground to 41% for making progress. This difference can be attributed to growing concern and awareness about the opioid epidemic, which has seen many individuals fall victim to drugs such as fentanyl. The shift may also reflect increased awareness on…

TuesdayNov 21, 2023 4:20 pm

420 with CNW — Could Rescheduling Make Marijuana Interstate Commerce Possible?

There is optimism among some marijuana executives that the federal government’s potential reclassification of cannabis from Schedule 1 to Schedule 3 could open the door for interstate commerce in marijuana products. However, legal experts in the marijuana industry caution that this optimism is only partially warranted. Schedule 3, along with Schedules 4 and 5, currently allows interstate commerce only for drugs that have received approval from the FDA. This approval includes drugs such as testosterone, ketamine, anabolic steroids and certain formulations of THC, such as Syndros, Marinol and dronabinol. The crucial factor, according to Bianchi and Brandt attorney Justin Brandt,…

TuesdayNov 21, 2023 4:20 am

420 with CNW — Congressional Researchers Say High Federal Taxes on Marijuana May Hamper Industry’s Economic Potential

The Congressional Research Service recently published a report that cautions legislators to consider the possible consequences of levying high taxes on cannabis products in the event that marijuana gets legalized federally. This comes as Congress considers several reform initiatives and the DEA concludes its review of marijuana scheduling and makes a decision on whether or not to reclassify cannabis as a Schedule 3 drug under the Controlled Substances Act, as recommended by the U.S. Health and Human Services Department. In a previous report, the nonpartisan research body argued that the DEA was likely to reschedule cannabis based on previous precedents.…

MondayNov 20, 2023 4:20 pm

420 with CNW — Survey Shows Growing Investor Interest in Cannabis MSOs

A recent survey indicates a growing optimism among institutional investors towards U.S. marijuana multistate operators (MSOs). Conducted by Calgary-based ATB Capital Markets, the survey involved 23 institutional investors, primarily hedge funds. Frederico Gomes, the lead author of the report and a marijuana equity analyst, highlighted the increased bullish sentiment among investors, driven primarily by the potential rescheduling of marijuana by the federal government. The survey reveals that about 61% of respondents believe U.S. marijuana MSOs will outperform the S&P 500 in the next year. However, despite this positive sentiment, Gomes notes that the capital influx has not yet aligned with…